Rachel Lee Patient Advocacy Consulting
  • Home
    • Meet Rachel Lee
    • Meet The Team
    • Advocacy Principles
    • Privacy Statement
  • Patient Services
    • What is Patient Advocacy Consulting at RLPAC?
    • Appointments
    • What do we do at a consult?
    • New Client Forms
  • Speaking Out
    • Advocacy Equipping
    • Public Speaking
    • About Advocacy & Training Resources
  • Patient Resources
    • General Resources & Basic Support
    • Gastro and Mast Cell
    • Dysautonomia and Neurology
    • Spine and Brain
    • Neuropathy and Autoimmune
  • Medical Professionals
  • Blogs
  • Contact
Select Page
RE-BLOG: Statement on the use of opioids in pain management of the Ehlers-Danlos syndromes and hypermobility spectrum disorders

RE-BLOG: Statement on the use of opioids in pain management of the Ehlers-Danlos syndromes and hypermobility spectrum disorders

by RachelLee | Oct 6, 2021 | Patients, Physicians

Posted September 30, 2021 A statement from The Ehlers-Danlos Society and the EDS and HSD International Consortium Pain Working Group. Pain is common among persons living with the Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD) and is a major...

Archives

  • July 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021

Categories

  • General
  • Genetics
  • Patients
  • Physicians

Recent Posts

  • Low Histamine: Is Your Anti-Inflammatory Diet Really Doing its Job?
  • The Fight for Water: Dehydration and Vascular Access needs in Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders
  • ECHO Summit: Neurology in EDS & HSD
  • RE-BLOG: Statement on the use of opioids in pain management of the Ehlers-Danlos syndromes and hypermobility spectrum disorders
  • Genetics Realities and What you Can Do about it

Recent Comments

  1. Mark on A Cultural Approach to Long Term Health
  • Facebook
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress